Solid Biosciences Inc.
Solid Biosciences is a precision genetic medicine company focused on developing gene therapy candidates for rare neuromuscular and cardiac diseases, including Duchenne muscular dystrophy and Friedreich’s ataxia. The company also develops enabling technologies and genetic regulators to support gene therapy delivery.
2026 Price Target
$17.38
Average analyst target
Currency
Monetary values are shown in your selected currency.
Friday, September 4
Low
$10.21
High
$10.42
Cost of Shares
—
Simulated Profit
—
Simulated results compare the selected period's low and high and do not represent an actual trade. Fees, taxes, slippage, and the ability to execute at exact prices are not included.
Reported Profit
$0
0 profit reports
Reported Loss
$0
0 loss reports
Net Reported
$0
0 total reports
No community outlook yet.
Be the first to vote when a poll becomes available.
Solid Biosciences Inc. Previous-Day Levels Previous session: Friday, September 4, 2026 High: $10.42 Low: $10.22 Close: $10.25 Support: $10.22 | $10.27 Resistance: $10.36 | $10.42 Why these levels matter: Buyers defended the $10.22 session low multiple times, while midday rallies repeatedly...
Community sentiment and reported results reflect voluntary member input and should not be interpreted as investment advice or verified performance.